Wuhan, September 20, 2024 — At the grand opening of the 2024 Conference on Pharmaceutical Quality Control Technology (CPQC2024 – Wuhan), Singedi Health Technology Co., Ltd. made a remarkable appearance with its flagship digital platform OwlTrust® and supporting product suite. During the industry summit, Singedi presented its innovative digital solutions tailored for quality control across the pharmaceutical sector to all attendees.

I. OwlTrust® Digital Platform

Hippocrates’s OwlTrust® digital platform stood out as the highlight at the exhibition booth. Integrating core modules including quality management, document management, training management, pharmacovigilance and electronic signature, the platform delivers efficient and fully compliant digital solutions for pharmaceutical manufacturers. Hippocrates's team of professional technical engineers delivered in-depth product demonstrations and detailed technical consultations for on-site visitors, enabling every guest to fully appreciate the value OwlTrust® brings to GMP-compliant pharmaceutical management.

Hippocrates's booth drew crowds of industry clients, who showed strong interest in the company’s digital offerings. Hippocrates's profound expertise and extensive industry track record won high recognition from visitors, with numerous clients engaging in in-depth technical exchanges with the team on site.

Hippocrates Health Technology Co., Ltd. will keep driving digital transformation within the pharmaceutical industry through technological innovation. Aligning closely with evolving industry trends, the company will continuously upgrade its products and services to meet clients’ diverse requirements.Hippocrates looks forward to establishing partnerships with more enterprises to collectively advance high-standard, high-quality development of the pharmaceutical industry.

02 About Hippocrates

Named after Hippocrates, the father of ancient Greek medicine, Hippocrates has over 20 years of industry experience. The company started with GMP compliance consulting and has grown into a leading provider of pharmaceutical digital solutions in China. We have participated in the drafting of national GxP digital standards and possess strong capabilities in both consulting and independent R&D. Our products comply with GxP standards and meet the regulatory requirements of global authorities such as the NMPA, FDA, EMA, and WHO. Our self-developed QMS, DMS, and TMS suites rank among the top tier in China. We also offer VDR, eSIGN, PVS, EBR, WMS, CGT, and eMAH solutions, along with one-stop services covering compliance control, data governance, and CSV validation, supporting both group-level and global deployment. Our clients include leading domestic pharmaceutical companies, benchmark biotech enterprises, and multinational pharmaceutical companies. To date, we have helped hundreds of companies achieve zero-defect audits, empowering pharmaceutical enterprises in digital transformation, cost reduction, efficiency improvement, and global growth.